drugset
drugset / Trial / NCT06682117

A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor

NCT06682117 ↗

Recruiting 9 enrolled Fudan University
NaSingle-groupOpen-labelTreatment

Summary

This is a clinical study of personalized self-DC vaccine targeting neo-antigen (Neo-DC vaccine) in the treatment of advanced solid tumors.

Timeline

Start
2024-11-15
Primary completion
2026-12-30
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject DC vaccine Vaccine 1e+07 cells Other
Subject DC vaccine Vaccine 5e+07 cells Other

Indications

No indication recorded.